Holen Sie sich die Stockscreener-App
15.31
2.17%
-0.34
Omada Health Inc Aktie (OMDA) Neueste Nachrichten
Omada Health (NASDAQ:OMDA) Trading Down 5.1%What's Next? - MarketBeat
Shareholders Should Be Pleased With Omada Health, Inc.'s (NASDAQ:OMDA) Price - 富途牛牛
Digital Therapeutics Market to Reach US$ 39.52 Billion by 2033 - openPR.com
Omada Health (NASDAQ:OMDA) Shares Gap DownWhat's Next? - MarketBeat
Omada Health: Business Is Scaling Very Healthily (NASDAQ:OMDA) - Seeking Alpha
Franklin Resources Inc. Makes New Investment in Omada Health, Inc. $OMDA - MarketBeat
Digital Health Coaching Market Size Worth $28.40 Billion by 2032, Drive by AI-Driven Personalization and Rising Demand for Preventive Care – SNS Insider - GlobeNewswire Inc.
Is OMDA Stock Set for a Rebound? - StocksToTrade
Certain Stock Options of Omada Health, Inc. are subject to a Lock-Up Agreement Ending on 3-DEC-2025. - MarketScreener
Certain Warrants of Omada Health, Inc. are subject to a Lock-Up Agreement Ending on 3-DEC-2025. - marketscreener.com
Certain Common Stock of Omada Health, Inc. are subject to a Lock-Up Agreement Ending on 3-DEC-2025. - marketscreener.com
Certain Series A Preferred Stock of Omada Health, Inc. are subject to a Lock-Up Agreement Ending on 3-DEC-2025. - marketscreener.com
HBK Investments L P Invests $1.37 Million in Omada Health, Inc. $OMDA - MarketBeat
1,090,056 Shares in Omada Health, Inc. $OMDA Acquired by Loomis Sayles & Co. L P - MarketBeat
Omada Health, Inc. (NASDAQ:OMDA) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Omada Health, Inc.'s (NASDAQ:OMDA) Lock-Up Period To End on December 3rd - MarketBeat
Oversold Conditions For Omada Health (OMDA) - Nasdaq
Omada Health to Participate in Evercore Healthcare Conference - The Manila Times
United States 7MM Digital Therapeutics for Diabetes Market: FDA - openPR.com
Omada Health’s Strategic Growth and Profitability: A Buy Rating by Craig Hettenbach - TipRanks
Omada Health's Integrated Approach Powers Growth in Digital Therapeutics () - aktiencheck.de
OMDA: BMO Capital Initiates Coverage with "Outperform" Rating | - GuruFocus
Thought bubble: Omada's about-face - Axios
Omada Health initiated with an Outperform at BMO Capital - TipRanks
Omada Health Positioned for Growth with Strong Financial Performance and Strategic Market Opportunities - TipRanks
EBIT per share of Omada Health, Inc. – MUN:U76 - TradingView
Inside Omada's pivot toward GLP-1 prescriptions - Axios
Cash from financing activities of Omada Health, Inc. – FWB:U76 - TradingView
Omada Health Reports Strong Q3 2025 Growth - MSN
How Trump’s GLP-1 move may affect telehealth companies’ fortunes - Modern Healthcare News
Free cash flow per share of Omada Health, Inc. – MUN:U76 - TradingView
Omada Health, Inc. Earnings and Revenue – MUN:U76 - TradingView
Omada Health (OMDA): Assessing Valuation After Recent Stock Declines - Yahoo Finance
Latin America Digital Therapeutics Market Poised - openPR.com
Omada Health Stock Jumps Into Retail Focus As Wall Street Lifts Price Targets After ‘Beat And Raise’ Quarter, GLP-1 Push - Stocktwits
Omada Health, Inc. Balance Sheet – FWB:U76 - TradingView
Omada Health announces GLP-1 prescribing capability - MSN
Omada Health raises FY25 revenue view to $251.5M-$254.5M from $235M-$241M - MSN
Omada Health reports Q3 EPS (6c), consensus (7c) - MSN
Omada Health Reports Strong Growth and Innovation - MSN
Omada Health price target raised to $32 from $30 at Morgan Stanley - MSN
Needham & Company LLC Issues Positive Forecast for Omada Health (NASDAQ:OMDA) Stock Price - MarketBeat
Omada Health price target raised to $28 from $27 at Evercore ISI - MSN
Evercore ISI Group Maintains Omada Health (OMDA) Outperform Recommendation - MSN
Why Omada Health is finally prescribing Ozempic as TrumpRx slashes GLP-1 weight-loss drug costs - Business Insider
Omada Health Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Omada Health to prescribe GLP-1s - TechTarget
Evercore ISI Group Raises Price Target for OMDA to $28.00 | OMDA Stock News - GuruFocus
Omada Health, Inc.: Strong Revenue Momentum and Strategic Partnerships Drive Buy Rating - TipRanks
Omada Health to present RWE on behavior change program at ObesityWeek - MSN
Omada Health, Inc.: Strong Market Position and Growth Potential Drive Buy Rating - TipRanks
Omada Health Inc (OMDA) Q3 2025 Earnings Call Highlights: Record Membership Growth and ... By GuruFocus - Investing.com Canada
Omada Health Reports Third Quarter 2025 Results - The Manila Times
Omada Health Q3 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: Omada Health Q3 2025 sees revenue growth, stock dips - Investing.com India
Compared to Estimates, Omada Health, Inc. (OMDA) Q3 Earnings: A Look at Key Metrics - Yahoo Finance
1.74%
4.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):